OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.
Clinical trial NCT01842620 · COMPLETED
Trial details
- NCT number
- NCT01842620
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-13
- Primary completion
- 2013-05-04
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.